Comparative assessment of efficacy and safety of ambrisentan and bosentan in patients with pulmonary arterial hypertension: A meta-analysis.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of clinical pharmacy and therapeutics"
DOI: 10.1111/jcpt.13481
Abstract: WHAT IS KNOWN AND OBJECTIVE Two endothelin receptor antagonists, ambrisentan and bosentan, have been demonstrated to be effective individually compared with placebo in the treatment of patients with pulmonary arterial hypertension (PAH). This network meta-analysis… read more here.
Keywords: bosentan patients; sucra score; score ambrisentan; ambrisentan bosentan ... See more keywords